We partner with leading pharmaceutical, biotechnology, and diagnostic companies to support and strengthen OCRA's mission.
As the leading ovarian cancer organization in the world, we recognize that stakeholder collaboration is key to achieving our goal of curing gynecologic cancers and ensuring the development of safe, more effective therapies. We work with our partners to fulfill our shared goals of raising awareness, supporting patients, emphasizing education, and advancing critical research and treatment options.
Partnering with OCRA helps bring your clinical work full circle, supporting patients through every stage of their journeys. By collaborating with us, industry partners gain a better understanding of patient needs, helping ensure developments that address their concerns, while gaining an increased focus on real-world data.
We have a number of year-round sponsorship and support opportunities for partners, from patient support and education, to advocacy, to our International Conference, as well as our Gynecologic Cancer Collaborative. OCRA also engages with partners to increase awareness through unbranded communications campaigns and opportunities to elevate the patient voice in therapy development. Please contact us if you wish to learn more about our work and how we can partner to better serve and support the gynecologic cancer community.
At present, OCRA does not engage with partners for paid advertisements on our website or digital/print publications and newsletters. We do have opportunities for brand awareness and advertisements via our International Gynecologic Cancer Conference.
For more information, please contact Jessica Hughson-Andrade at jhughson-andrade@ocrahope.org
OCRA is excited to see the work fueled by our new AI Accelerator Grant resonating with a broad array of audiences. Since the Global Ovarian Cancer Research Consortium announced the inaugural AI Accelerator Grant on February 19, coverage has appeared across health, science, and business media outlets. The $1 million global research award—with an additional … Continued
The Global Ovarian Cancer Research Consortium and its inaugural AI Accelerator Grant have been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients. The $1 million global research grant, plus an additional $1 million in compute support from Microsoft’s AI for Good Lab, will fund … Continued
Recognizing Advances in Ovarian Cancer Research and Immunotherapy Ovarian Cancer Research Alliance (OCRA) announced today the winners of two prizes recognizing exceptional accomplishments in ovarian cancer research. David Huntsman, MD, FRCPC, FCCMG, was awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research for his findings that have profoundly impacted the treatment of … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
